I. Kaysudu Et Al. , "Cholesterol biogenesis is a PTEN-dependent actionable node for the treatment of endocrine therapy-refractory cancers," CANCER SCIENCE , vol.114, no.11, pp.4365-4375, 2023
Kaysudu, I. Et Al. 2023. Cholesterol biogenesis is a PTEN-dependent actionable node for the treatment of endocrine therapy-refractory cancers. CANCER SCIENCE , vol.114, no.11 , 4365-4375.
Kaysudu, I., Gungul, T. B., Atici, S., Yilmaz, S., Bayram, E., GÜVEN, G., ... Cizmecioglu, N.(2023). Cholesterol biogenesis is a PTEN-dependent actionable node for the treatment of endocrine therapy-refractory cancers. CANCER SCIENCE , vol.114, no.11, 4365-4375.
Kaysudu, Irmak Et Al. "Cholesterol biogenesis is a PTEN-dependent actionable node for the treatment of endocrine therapy-refractory cancers," CANCER SCIENCE , vol.114, no.11, 4365-4375, 2023
Kaysudu, Irmak Et Al. "Cholesterol biogenesis is a PTEN-dependent actionable node for the treatment of endocrine therapy-refractory cancers." CANCER SCIENCE , vol.114, no.11, pp.4365-4375, 2023
Kaysudu, I. Et Al. (2023) . "Cholesterol biogenesis is a PTEN-dependent actionable node for the treatment of endocrine therapy-refractory cancers." CANCER SCIENCE , vol.114, no.11, pp.4365-4375.
@article{article, author={Irmak Kaysudu Et Al. }, title={Cholesterol biogenesis is a PTEN-dependent actionable node for the treatment of endocrine therapy-refractory cancers}, journal={CANCER SCIENCE}, year=2023, pages={4365-4375} }